Ablynx Announces Warrant Exercise

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

GHENT, Belgium, Oct. 21, 2013 (GLOBE NEWSWIRE) -- Ablynx [Euronext Brussels: ABLX] today announced, in conformity with Title II of the Law of 2 May 2007 and the Royal Decree of 14 February 2008, that an additional 25,531 common shares have been issued by the Company in exchange for 147,161.69 Euro as the result of the exercise of warrants by some employees and consultants of the Company.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC